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High -density lipoprotein cholesterol as a predictor for 
diabetes mellitus 
 
 
Abstract 
Background: Diabetes is a prevalent chronic disease around the world. To evaluate the 
risk of diabetes comprehensively, we developed a score model for risk prediction with 
HDL-C as a protective factor. 
Methods: We extracted physical examination data of 2728 individuals. The data contain 
18 demographic and clinical variables. To identify the statistical significant feature 
variables, the backward stepwise logistic regression was used based on the data of the 
“exploratory population”. To ascertain the cutoff value of the selected variables, we used 
the Youden index. Then we assigned each variable level a score according to the estimated 
regression model coefficients and then calculated the individual’s total score. We gained 
the cutoff value for the total score through the Youden Index and stratified the total score 
into four levels. We employed the data of “validation population” to test the performance 
of the score model based on the area under the ROC curve. 
Results: Age, LDL-C, HDL-C, BMI, family history of diabetes, diastolic blood pressure 
and TCHO were selected as statistically significant variables. The diabetes risk score range 
varied from 0 to 17. The risk level categorized by the total score was low, middle, high and 
extremely high, with a score range of 0-2, 3-7, 8-12 and 13-17,  respectively. 
Conclusions: The score model based on physical examination data is an efficient and 
valuable tool to evaluate and monitor the potential diabetes risk for both healthy and 
unhealthy people at an individual level. 
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Diabetes mellitus is a prevalent chronic disease worldwide as a normal and serious 
health issue (1, 2). Studies showed that the prevalence of diabetes mellitus is becoming an 
urgent and important public health problem for Chinese adults (3). Diabetes can result in 
or promote the incidence of a set of complications, like depression (4, 5), diabetic 
retinopathy (6-8). Some studies have proven the association between intensive lifestyle 
intervention and the remission of type 2 diabetes (9). It has been proven that the prevention 
of the onset of type 1 diabetes or the reduction of the risk of type 2 diabetes through 
interventions were possible and feasible (10, 11). Now, the major concern for patients with 
diabetes, would be the individual diabetes risk evaluation and the related early 
implementation of health interventions. Physical examination is widely used to check up 
the personal physical condition. However, it is time-consuming and would lead to overload 
of work for the doctors since many of the medical examinations were performed at the end 
of month or year in China. Such a practical way of the self-health evaluation is of great 
importance to alleviate the medical resource strain and the doctor’s workload, especially 
for a poor and unevenly distributed medical resource environment in China. Many of the 
existing diabetes score models are based on the questionnaire or survey data (12, 13).  
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Some were focused on the physiological parameter (14, 
15). Research shows that the incidence of diagnosed type 2 
diabetes for the people in Harbin, China has experienced a 
dramatical increase in recent years with the annual rate 
reaching 12% (16). The prevention of diabetes is of great 
importance and urgency. However, the diabetes risk pattern 
for the people in Harbin, northeastern China, which is a 
diabetes prevalent site, has not been studied. 
The main goal for our research was to set up a 
comprehensive and ready-to-use scoring model to identify 
the risk factors of diabetes mellitus and construct a risk score 
according to the physical examination data. Also, we verified 
the scoring model performance with the data of a “validation 
population”. 
 
 
Methods 
Study design and population: This was a methodological 
study which was designed for local doctors to help them 
evaluate the patient’s diabetes risk more easily and 
conveniently. We extracted the medical examination data of 
2728 subjects with age greater than 20 in 2014 from the 
School Hospital in HIT. We assigned the subjects into two 
groups: the exploratory group and validation group. If the 
number of subjects distincted from the two groups, the 
robustness and performance of the score model would be 
affected heavily. To make our score model robust, we 
attempted to minimize the difference between the two goups 
when cutting them into two balanced parts. And to guarantee 
performance of the score model, the exploratory population 
was assigned some more subjects. In detail, among them, 
1465 subjects were randomly selected into the “exploratory 
population”, based on which a score model was developed. 
The remaining subjects were used for the model validation 
as the “validation population”. The screening criteria of 
diabetes were focused on the fasting plasma glucose, with 
the level of fasting plasma glucose higher than 7.0mmol/L 
would be diagnosed as diabetes (17). 
The research was approved by the Ethics Committee of 
the School Hospital of Harbin Institute of Technology. For 
confidetiality, all of the names and the medical exmination 
document numbers were deleted by the School Hospital of 
Harbin Institute of Technology. 
Statistical analysis: The statistical analysis was performed 
with R program (18). All continuous data were expressed as 
the mean±standard deviation or median depending on 
normality. Differences between groups were assessed by the 
two-sample t-test. For categorical data, chi-square test was 
used for comparison. We initially selected 18 potential risk 
factors for the development of the score model. These 
potential risk factors were: age, gender, BMI, personal 
history of hypertension, personal history of coronary heart 
disease, personal history of cerebrovascular diseases, family 
history of hypertension, family history of diabetes, family 
history of coronary heart disease, family history of 
cerebrovascular diseases, smoking or not smoking, drinking 
or not drinking  systolic blood pressure, diastolic blood 
pressure, triglyceride, Total Cholestrol (TCHO), High 
Density Lipoproteine Cholestrin (HDL-C), and Low Density 
Lipoproteine Chilostrin (LDL-C). A backward stepwise 
logistic regression model was used to screen out the 
statistically significant factors. A p-value of less than 0.05 
was considered to be statistically significant. The significant 
factors were then used to construct the scoring model. Based 
on the receiver operation characteristic (ROC) curve of the 
selected variables, the cutoff value of each variable was 
obtained by calculating the Youden index to formulate the 
scale of the scoring model. We calculated the total score of 
each subject to better understand the risk of diabetes. The 
total score was then included into a binary logistic regression 
model and the Youden index was used to determine the 
cutoff value of the total score according to the ROC curve. 
Based on each subject’s total score, we divided the total risk 
into four status levels: low risk, middle risk, high risk and 
extremely-high risk.  
Score model test was important to check the accuracy or 
efficiency of the model. We validated the performance of the 
diabetes risk score model via the “validation population”. 
The area under the ROC curve (AUC) was usually used to 
test the accuracy of the score model. If AUC was larger than 
0.5, it would be considered that the performance of the 
model is valid. First, we obtained the total score for each 
subject in the “validation population” based on the score 
model. We then calculated the area under the ROC curve 
(AUC) to evaluate the performance of the score model. 
 
 
Results 
In both the exploratory and validation populations, most 
of the characteristics were non-significant except for family 
history of diabetes (table 1), which suggesting that the 
comparability between the two populations groups was 
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rather good. By the logistic regression, the significant risk 
factors for the score model were age, LDL-C, BMI, family 
history of diabetes, HDL-C, diastolic blood pressure and 
TCHO (table 2).  
Among them, age, BMI, family history of diabetes, 
diastolic blood pressure and TCHO appeared to be risk 
factors because the related coefficients were positive while 
HDL-C and LDL-C appeared to be preventive factors due to 
their negative coefficients. Previous studies suggested that 
LDL-C was a risk factor for diabetes (19) while HDL-C was 
a preventive factor (20, 21), thus in our model, we 
considered the LDL-C as a risk factor. BMI was marginally 
significant and some studies showed that it was a significant 
risk factor for diabetes (22, 23), so we included it into our 
model. As shown in table 2, the AUC for the integrated 
model was 0.834 (95%CI, 0.802-0.867), which is much 
higher than the AUC of any single factor. It was suggested 
that we should evaluate the risk of diabetes by combining all 
the statistically significant, marginally significant factors 
together.  
 
Table 1. Basic demographic and clinical characteristics of the “exploratory population” and “validation population”. 
 
 Diabetes Non-diabetes 
Characteristic 
Exploratory 
group 
Validation 
group 
p-value 
Exploratory 
group 
Validation 
group 
p-value 
n 105 105 -- 1360 1158 -- 
Gender (male) 64 67 0.776 737 650 0.350 
Age (years) 64.82±13.79 66.79±13.59 0.298 51.44±17.59 51. 46±17.62 0.978 
BMI* (kg/m
2
) 26.31±2.90 26.35±3.16 0.921 24.35±3.52 24.35±3.42 0.958 
Diastolic blood pressure (mmHg) 83.05±10.11 82.01±9.34 0.441 76.79±10.43 77.71±10.49 0.029 
Family history of diabetes (Yes) 24 2 <0.0001 128 1153 <0.0001 
LDL-C ** (mmol/L) 3.15±1.06 3.04±1.15 0.492 2.76±0.92 2.75±0.93 0.896 
HDL-C *** (mmol/L) 1.57±0.42 1.60±0.49 0.639 1.83±0.54 1.81±0.51 0.349 
TCHO **** (mmol/L) 5.17±1.19 5.11±1.41 0.739 4.86±0.92 4.83±0.93 0.504 
FPG***** (mmol/L) 9.25±2.30 9.19±2.24 0.849 5.32±0.56 5.32±0.53 0.772 
*Body Mass Index                  **Low Density Lipoproteine Chilostrin            ***High Density Lipoproteine Cholestrin 
****Total Cholestrol              *****Fasting plasma glucose 
 
Table 2. Backward stepwise logistic regression model and the cutoff values of related risk factors 
 
Variable Coefficient p value Odds ratio AUC(95% CI) Cutoff value 
Age (years) 0.057 <0.0001 1.058 0.719(0.677-0.762) 53 
LDL-C* (mmol/L) -1.766 <0.0001 0.171 0.608(0.549-0.667) 2.98 
BMI** (kg/m
2
) 0.071 0.0508 1.074 0.666(0.619-0.608) 23.6 
Family history of diabetes (Yes) 1.235 <0.0001 3.437 0.567(0.526-0.608)  
HDL-C*** (mmol/L) -2.643 <0.0001 0.071 0.645(0.541-0.705) 1.705 
Diastolic blood pressure (mmHg) 0.033 0.0029 1.033 0.664(0.616-0.713) 75 
TCHO**** (mmol/L) 1.817 <0.0001 6.152 0.579(0.517-0.641) 5.6 
Area under the ROC curve 0.834, 95%CI (0.802-0.867)   
*Low Density Lipoproteine Chilostrin                  **Body Mass Index  
***High Density Lipoproteine Cholestrin             ****Total Cholestrol 
 
To better evaluate the effects of risk factors in the score 
model, we categorized the selected continuous factors, 
mainly age, BMI, LDL-C, HDL-C and diastolic blood  
 
pressure, into three levels according to the cutoff values as  
shown in table 2. For most of the selected factors, the higher 
the level was, the higher risk it presented, except for the 
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preventive factor of HDL-C. For HDL-C, the level higher 
than the cutoff value of 1.705 was considered as the 
reference level. For TCHO, we categorized it into two levels 
due to the data restriction. The result of the categorization 
was shown in table 3.  
The score was attributed mainly from the β-coefficient. 
The principal of the score attribution was described as 
follows: β=0.01-0.2, the corresponding score was assigned 1; 
β=0.21-0.8, the score was 2; β=0.81-1.2, the score was 3; 
β=1.21-2.2, the score was 4; β>2.2, the score was assigned 
the highest of 5 (24). Based on these individual scores, we 
calculated the total score of the “exploratory population”, 
and obtained the cutoff value of the total score based on its 
ROC curve.  
The cutoff value of the total score was 7.5. We then 
categorized the total score into four levels for the risk 
stratification: low risk (the total score of 0-2), middle risk (3-
7), high risk (8-12) and extremely-high risk (13-17). 
Table 3．Logistic regression model with the stratified risk factors and the related scoring system. 
 Coefficient Odds ratio (95% CI) Score 
Intercept -5.223   
Age (years)    
<=53 reference  0 
54-68 1.116 3.051 (1.722-5.443) 3 
69-91 1.844 6.321 (3.723-10.996) 4 
LDL-C* (mmol/L)    
<=2.98 reference  0 
2.99-5.07 0.102 1.107 (0.654-1.852) 1 
5.08-8.07 1.576 4.835 (1.477-15.162) 4 
BMI** (kg/m
2
)    
<=23.6 reference  0 
23.7-29.9 0.777 2.175 (1.255-3.939) 2 
30.0-38.0 0.824 2.279 (0.890-5.495) 3 
Family history of diabetes    
No reference  0 
Yes 1.250 3.489(1.994-5.979) 4 
HDL-C*** (mmol/L)    
>=1.705 reference  0 
0.83-1.704 0.956 2.602(1.618-4.268) 3 
0.78-0.82 1.381 3.980(0.176-39.921) 4 
Diastolic blood pressure (mm Hg)    
<=75 reference  0 
76-98 0.297 1.346(0.826-2.244) 2 
99-128 1.120 3.064(1.223-7.153) 3 
TCHO**** (mmol/L)    
<=5.6 reference  0 
>5.6 0.305 1.357(0.737-2.475) 2 
Area under the ROC curve 0.811, 95% CI(0.776-0.847)  
*Low Density Lipoproteine Chilostrin                **Body Mass Index 
***High Density Lipoproteine Cholestrin             ****Total Cholestrol 
 
Finally, we checked the performance of the score model 
with the “validation population” of 1263 subjects. Among 
them, 105 (8.31%) subjects were diagnosed with diabetes.  
 
We calculated the total score of each subject in the 
“validation population”, based on the score model developed 
from the “exploratory population”. The AUC for the total 
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score was 0.770 (95%CI: 0.730-0.811) (fig 1). The AUC’s 
value was larger than the cutoff value of 0.5 which indicated 
that the performance of the score model was relatively good 
for predicting the risk of diabetes for the “validation 
population”. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. ROC curve of the total risk score for the “Validation 
population”. The AUC was 0.770 (95%CI: 0.730-0.811). 
 
Discussion 
In this study, we construted a diabetes score model based 
on the physcial examination report data. The risk factors we 
selected for constructing the diabetes score model were age, 
LDL-C, BMI, family history of diabetes, HDL-C, diastolic 
blood pressure, TCHO. Based on the calculation of the 
diabetes score model, we then divided the risk level into four 
categories: low risk (0-2), middle risk (3-7), high risk (8-12) 
and extremely high risk (13-17). Validation of the diabetes 
risk model showed a good performance of the diabetes score 
model. 
Studies have shown that diabetes could have been 
prevented through the related interventions such as lifestyle 
intervention or education (25, 26). Therefore, there is a 
strong favor in screening the potential patients who are at 
high risk of developing diabetes. Our study is unique that we 
focused our research on a variety of subject’s demographic 
and clinical characteristics, which can give a better 
integrated evaluation of the diabetes risk status. This may 
provide a simple, practical and useful tool for potential high-
risk diabetes individuals to make a proper identification after 
they received the physical examination reports. The 
identified high-risk individuals would benefit from receiving 
health interventions at an early stage so as to prevent the 
onset of diabetes. It is highly recommended that the high-risk 
individuals seek appropriate health interventions. Unlike 
other risk score models developed elsewhere, our research 
utilized the data from physical examination reports in which 
the related demographic and clinical data were convenient to 
be collected from the hospital systems. Compared with other 
studies, our data collection was easier and it could be applied 
in our hospitals directly. The score model and its use in self-
assessment might be a good way to alleviate the workload of 
doctors since many of the physical examinations were 
conducted at the end of the month or year. 
HDL-C appeared to be a protective factor in our study. 
The result was consistent with other studies that HDL-C, a 
component of the metabolic syndrome, was beneficial to 
prevent the diabetes. For other risk factors in the score 
model, a value above the corresponding cutoff value 
typically indicated a higher risk of diabetes. A major 
contribution of the integrated score model is that HDL-C 
was included to capture its preventive function. However, we 
excluded the drinking and smoking factors in the model 
development due to possibly oversimplified quantification of 
these two risk factors. Also, since the information on 
physical activity and diet was not collected in the physical 
examination reports, their effects cannot be assessed or taken 
into consideration into the score model.  
Further research is needed to explore the roles of these 
factors in risk prediction of diabetes.Compared with the 
existing diabetes score models (12, 27, 28), our model is 
innovative in that we stratified the total score into four risk 
levels, which would make the results easier to be interpreted 
by the users. More importantly, we tested the performance of 
the score model through the “validation population”. The 
validation result confirmed that our risk score model has a 
good and robust performance in the prediction of the risk of 
diabetes even though some of the risk factors showed a 
significant difference between the two groups. 
In conclusion, we developed a ready-to-use diabetes risk 
score model based on the physical examination data which 
can be applied as a tool to identify individuals at high risk of 
diabetes. It consisted of the positive predictors, such as age 
(p<0.0001), LDL-C (p<0.0001), BMI (p=0.0508), family 
history of diabetes (Yes, p<0.0001), HDL-C (p<0.0001), 
diastolic blood pressure (p=0.0029), TCHO (p<0.0001), as 
well as negative predictors TCHO (p<0.0001). People can 
use it to make a self-assessment based on the data from their 
physical examination report. 
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